BioMarin Pharmaceutical
BMRN
#1442
Rank
NZ$20.60 B
Marketcap
$108.10
Share price
-3.32%
Change (1 day)
-25.14%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: NZ$20.60 Billion

As of November 2024 BioMarin Pharmaceutical has a market cap of NZ$20.60 Billion. This makes BioMarin Pharmaceutical the world's 1442th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$20.60 B-28.27%
2023NZ$28.71 B-5.2%
2022NZ$30.29 B27.57%
2021NZ$23.74 B7.64%
2020NZ$22.06 B-2.28%
2019NZ$22.57 B-0.22%
2018NZ$22.62 B2.62%
2017NZ$22.05 B7.21%
2016NZ$20.56 B-16.81%
2015NZ$24.72 B43.73%
2014NZ$17.20 B40.06%
2013NZ$12.28 B63.23%
2012NZ$7.52 B49.55%
2011NZ$5.03 B30.28%
2010NZ$3.86 B47.7%
2009NZ$2.61 B-14.61%
2008NZ$3.06 B-31.78%
2007NZ$4.48 B110.32%
2006NZ$2.13 B82.1%
2005NZ$1.17 B102.88%
2004NZ$0.57 B-24.58%
2003NZ$0.76 B5.71%
2002NZ$0.72 B-57.28%
2001NZ$1.69 B110.12%
2000NZ$0.80 B3.07%
1999NZ$0.78 B

End of Day market cap according to different sources

On Nov 15th, 2024 the market cap of BioMarin Pharmaceutical was reported to be:

NZ$20.60 Billion
by Yahoo Finance info icon info icon
NZ$20.60 Billion
by CompaniesMarketCap info icon info icon
NZ$20.60 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$7.04 B-65.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.72 B-96.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.71 B-96.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$213.99 B 938.69%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$4.93 B-76.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.18 B-79.67%๐Ÿ‡บ๐Ÿ‡ธ USA